Share on Pinterest Bariatric surgery may be better for preserving kidney function in people with diabetes and obesity than GLP-1 drugs. Image credit: Ruben Earth/Getty Images. In a new study ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

In the nonsurgical group, the most common GLP-1 medications were liraglutide and ... Researchers found that bariatric surgery ...

Glucagon-like peptide-1 ... (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney ...

These ectopic receptors influence GLP-1 and GIP secretion, serotonin and dopamine secretion, blood pressure, muscle ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

In fact, the molecular receptors for GLP-1 are sprinkled in many places around the body. They're found in the central nervous system, the heart, blood vessels, liver, and kidney. Their presence in ...

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking metabolic health to cognitive function. It suggests potential therapies for ...

since most GLP-1 agonists are taken as an injection,” comments Mitri. Still, more serious risks may include pancreatitis, gallbladder issues, kidney failure and an increased risk of thyroid ...

New research reveals how GLP-1 receptor drugs, known for treating diabetes and obesity, also protect the brain’s vital ...